Terminating Migraine-Associated Allodynia Using Oral Suspension Diclofenac: A Prospective Non-Randomized Drug Trial

Headache. 2017 Mar;57(3):478-486. doi: 10.1111/head.13031.

Authors

Catherine Buettner^{1

2}, Agustin Melo-Carrillo^{3

2}, Rami Burstein^{3

2}

Affiliations

¹ Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA.
² Harvard Medical School, Boston, MA, USA.
³ Department of Anesthesia and Critical Care, Beth Israel Deaconess Medical Center, Boston, MA, USA.

No abstract available

Publication types

Clinical Study
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

MeSH terms

Adolescent
Adult
Cyclooxygenase Inhibitors / therapeutic use*
Diclofenac / therapeutic use*
Female
Humans
Hyperalgesia / drug therapy*
Hyperalgesia / etiology*
Hyperalgesia / physiopathology
Middle Aged
Migraine Disorders / complications*
Migraine Disorders / drug therapy*
Migraine Disorders / physiopathology
Pain Measurement
Prospective Studies
Skin / drug effects
Skin / physiopathology
Treatment Outcome
Young Adult

Substances

Cyclooxygenase Inhibitors
Diclofenac

Grants and funding